News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Transition Therapeutics Inc. (TTH.TO) Announces ELND-005 Presentations at the American Academy of Neurology Meeting



4/26/2012 10:15:44 AM

TORONTO, April 26, 2012 (GLOBE NEWSWIRE) -- Transition Therapeutics Inc. ("Transition" or the "Company") (TSX:TTH) (Nasdaq:TTHI) announced that three ELND-005 poster presentations were presented yesterday at the American Academy of Neurology meeting in New Orleans, Louisiana. These presentations described responder analyses and characteristics, along with findings on the effect of ELND005 on the emergence of neuropsychiatric symptoms.

Read at GlobeNewswire

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES